ArticleJournal of market access & health policy2015
A review of accessibility of administrative healthcare databases in the Asia-Pacific region.
Article in Journal of market access & health policy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Indonesian National Health Insurance scheme longitudinal sample data 2015-2020: overview and potential uses for health policy analysis.BMC health services research · 2025Article
- Real-world data landscape for glaucoma in Europe: a questionnaire-based analysis of resources among European Glaucoma Society members.BMJ open ophthalmology · 2025Article
- Stroke Research Using Administrative Claims Database in Japan: A Narrative Review.Journal of atherosclerosis and thrombosis · 2024Review
- Studies of Health Insurance Claims Data in Japan: A Scoping Review.JMA journal · 2023Article
- The relationship of income on stroke incidence in Finland and China.European journal of public health · 2023Article
- A Review of Studies Using Japanese Nationwide Administrative Claims Databases.Annals of clinical epidemiology · 2023Review
- The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework.Clinical pharmacology and therapeutics · 2022Review
- A Content Review of Life Cycle Assessment of Nanomaterials: Current Practices, Challenges, and Future Prospects.Nanomaterials (Basel, Switzerland) · 2021Review
- Health claims databases used for kidney research around the world.Clinical kidney journal · 2021Review
- A global review of publicly available datasets for ophthalmological imaging: barriers to access, usability, and generalisability.The Lancet. Digital health · 2021Review
- Factors affecting access to administrative health data for research in Canada: a study protocol.International journal of population data science · 2021Article
- Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change.Journal of the American Heart Association · 2020Article
- National Health Insurance Databases in Indonesia, Vietnam and the Philippines.PharmacoEconomics - open · 2019Article
- Validation of claims data to identify death among aged persons utilizing enrollment data from health insurance unions.Environmental health and preventive medicine · 2019Article
- Key considerations when using health insurance claims data in advanced data analyses: an experience report.Health systems (Basingstoke, England) · 2019Article
- Observational
- Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China.Drug safety · 2018Article
- Assessment of Medication Safety Using Only Dispensing Data.Current epidemiology reports · 2018Review
- Epidemiology, microbiology, and treatment patterns of pediatric patients hospitalized with pneumonia at two hospitals in China: a patient chart review study.Therapeutics and clinical risk management · 2018Article
- Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective.Pneumonia (Nathan Qld.) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe describe and compare the availability and accessibility of administrative healthcare databases (AHDB) in several Asia-Pacific countries: Australia, Japan, South Korea, Taiwan, Singapore, China, Thailand, and Malaysia.
methodsThe study included hospital records, reimbursement databases, prescription databases, and data linkages. Databases were first identified through PubMed, Google Scholar, and the ISPOR database register. Database custodians were contacted. Six criteria were used to assess the databases and provided the basis for a tool to categorise databases into seven levels ranging from least accessible (Level 1) to most accessible (Level 7). We also categorised overall data accessibility for each country as high, medium, or low based on accessibility of databases as well as the number of academic articles published using the databases.
resultsFifty-four administrative databases were identified. Only a limited number of databases allowed access to raw data and were at Level 7 [Medical Data Vision EBM Provider, Japan Medical Data Centre (JMDC) Claims database and Nihon-Chouzai Pharmacy Claims database in Japan, and Medicare, Pharmaceutical Benefits Scheme (PBS), Centre for Health Record Linkage (CHeReL), HealthLinQ, Victorian Data Linkages (VDL), SA-NT DataLink in Australia]. At Levels 3-6 were several databases from Japan [Hamamatsu Medical University Database, Medi-Trend, Nihon University School of Medicine Clinical Data Warehouse (NUSM)], Australia [Western Australia Data Linkage (WADL)], Taiwan [National Health Insurance Research Database (NHIRD)], South Korea [Health Insurance Review and Assessment Service (HIRA)], and Malaysia [United Nations University (UNU)-Casemix]. Countries were categorised as having a high level of data accessibility (Australia, Taiwan, and Japan), medium level of accessibility (South Korea), or a low level of accessibility (Thailand, China, Malaysia, and Singapore). In some countries, data may be available but accessibility was restricted based on requirements by data custodians.
conclusionsCompared with previous research, this study describes the landscape of databases in the selected countries with more granularity using an assessment tool developed for this purpose. A high number of databases were identified but most had restricted access, preventing their potential use to support research. We hope that this study helps to improve the understanding of the AHDB landscape, increase data sharing and database research in Asia-Pacific countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.